Spatial Dynamics and High Risk Transmission Pathways of Poliovirus in Nigeria 2001-2013.
The polio eradication programme in Nigeria has been successful in reducing incidence to just six confirmed cases in 2014 and zero to date in 2015, but prediction and management of future outbreaks remains a concern. A Poisson mixed effects model was used to describe poliovirus spread between January 2001 and November 2013, incorporating the strength of connectivity between districts (local government areas, LGAs) as estimated by three models of human mobility: simple distance, gravity and radiation models. Potential explanatory variables associated with the case numbers in each LGA were investigated and the model fit was tested by simulation. Spatial connectivity, the number of non-immune children under five years old, and season were associated with the incidence of poliomyelitis in an LGA (all P < 0.001). The best-fitting spatial model was the radiation model, outperforming the simple distance and gravity models (likelihood ratio test P < 0.05), under which the number of people estimated to move from an infected LGA to an uninfected LGA was strongly associated with the incidence of poliomyelitis in that LGA. We inferred transmission networks between LGAs based on this model and found these to be highly local, largely restricted to neighbouring LGAs (e.g. 67.7% of secondary spread from Kano was expected to occur within 10 km). The remaining secondary spread occurred along routes of high population movement. Poliovirus transmission in Nigeria is predominantly localised, occurring between spatially contiguous areas. Outbreak response should be guided by knowledge of high-probability pathways to ensure vulnerable children are protected.
Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.
Tara D
TD
Mangal
World Health Organization (WHO), Geneva, Switzerland.
R Bruce
RB
Aylward
National Primary Healthcare Development Agency (NPHCDA), Abuja, Nigeria.
Faisal
F
Shuaib
World Health Organization (WHO), Amman, Jordan.
Michael
M
Mwanza
Duke Global Health Institute, Durham, North Carolina, United States of America.
Muhammed A
MA
Pate
National Primary Healthcare Development Agency (NPHCDA), Abuja, Nigeria.
Emmanuel
E
Abanida
Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.
Nicholas C
NC
Grassly
Wkly Epidemiol Rec. 2014 Apr 25;89(17):165-73
24772461
Malar J. 2014 Feb 10;13:52
24512144
Int Health. 2015 Mar;7(2):130-8
25733563
Science. 2006 Nov 17;314(5802):1150-3
17110580
J R Soc Interface. 2011 Feb 6;8(55):233-43
20573630
Am Nat. 2004 Aug;164(2):267-81
15278849
BMC Med. 2014 Jun 04;12:92
24894345
Sci Rep. 2014 Jul 14;4:5678
25022440
PLoS One. 2011 Jan 31;6(1):e16591
21304943
Trends Ecol Evol. 1997 Oct;12(10):395-9
21238122
Science. 2006 Apr 21;312(5772):447-51
16574822
Lancet Glob Health. 2014 Feb;2(2):e90-7
25104665
Nature. 2012 Feb 26;484(7392):96-100
22367540
N Engl J Med. 2010 Jun 24;362(25):2360-9
20573924